Generic Medicine Info
Hypertrophic obstructive cardiomyopathy, tachyarrhythmia.
Special Precautions
Patient w/ severe asthma, underlying severe heart disease (e.g. ischaemic heart disease, organic heart disease, arrhythmia, severe heart failure), insufficiently controlled DM, recent MI, hyperthyroidism, phaeochromocytoma, and severe vascular disorder. Pregnancy and lactation. Monitoring Parameters Monitor serum K levels.
Adverse Reactions
Hypokalaemia, hypersensitivity, nervousness, agitation, headache, dizziness, tremor, palpitations, myocardial ischaemia, tachycardia, arrhythmia, nausea, vomiting, hyperhidrosis, skin reactions (e.g. urticaria, rash, pruritus), myalgia, muscular weakness, muscle spasm, paradoxical bronchospasm, cough, throat irritation, increased systolic and decreased diastolic BP.
Drug Interactions
Increased effect w/ β-adrenergics, anticholinergics, MAOIs, TCAs and xanthine derivatives (e.g. theophylline). Serious reduction in bronchodilation w/ β-blockers. May enhance susceptibility to CV effects w/ halothane, enflurane, and trichloroethylene.
ATC Classification
G02CA03 - fenoterol ; Belongs to the class of sympathomimetics. Used as labour repressants.
R03AC04 - fenoterol ; Belongs to the class of adrenergic inhalants, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases.
R03CC04 - fenoterol ; Belongs to the class of adrenergics for systemic use, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases.
Disclaimer: This information is independently developed by CIMS based on fenoterol from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in